These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33362203)

  • 1. Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.
    Ryu H; Kim JH; Lee S; Han JK
    PLoS One; 2020; 15(12):e0244304. PubMed ID: 33362203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
    Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
    Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Savitzky-Golay filter based contrast-enhanced ultrasound quantification in hepatic tumors: Methodology and its correlation with tumor angiogenesis.
    Peng S; Ding H; Fu T; Wang B; Wang W; Zhou J
    Clin Hemorheol Microcirc; 2019; 73(2):271-282. PubMed ID: 30103307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
    Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
    Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of contrast-enhanced ultrasound quantitative parameters in the prognosis prediction of hepatocellular carcinoma after thermal ablation: a retrospective cohort study.
    Gu DY; Zhang Y; Hu JX; Qin HY; Lu X; He GB; Shang L
    J Gastrointest Oncol; 2022 Oct; 13(5):2522-2531. PubMed ID: 36388675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
    Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
    Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal elasticity and perfusion changes on ultrasonography in an early-stage diabetic rat model.
    Li Y; Liu ZS; Wei R; Liu ZW; Guo LX; Ren JH
    Quant Imaging Med Surg; 2023 Dec; 13(12):7667-7679. PubMed ID: 38106289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
    Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
    Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
    J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.
    Kim J; Kim JH; Yoon SH; Choi WS; Kim YJ; Han JK; Choi BI
    Ultrasound Med Biol; 2015 Dec; 41(12):3131-9. PubMed ID: 26365926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
    Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients.
    Schwarze V; Marschner C; Völckers W; de Figueiredo GN; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(2):155-160. PubMed ID: 32925017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model.
    Yang SH; Lin J; Lu F; Han ZH; Fu CX; Lv P; Liu H; Gao DM
    J Magn Reson Imaging; 2017 Jan; 45(1):270-280. PubMed ID: 27299302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
    Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
    J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1.
    Marschner CA; Zhang L; Schwarze V; Völckers W; Froelich MF; von Münchhausen N; Schnitzer ML; Geyer T; Fabritius MP; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(4):453-458. PubMed ID: 33216017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS).
    Wildner D; Schellhaas B; Strack D; Goertz RS; Pfeifer L; Fiessler C; Neurath MF; Strobel D
    Clin Hemorheol Microcirc; 2019; 71(1):39-51. PubMed ID: 29865043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.